AL-4943A ophthalmic solution, 0.2%
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AL-4943A ophthalmic solution, 0.2%, covering 2014-08-04 to 2014-08-04. Get the full timeline:
Most recent: Clinical Trial Update: An Open-Label, Long-Term Study With AL-4943A Ophthalmic Solution, 0.2% in Patients With Allergic Conjunctivitis [Phase 3]